Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
Irx Pharmaceuticals Private Limited, is an unlisted private company incorporated on 14 October, 2020. It is classified as a private limited company and is located in South Delhi, Delhi. It's authorized share capital is INR 1.00 lac and the total paid-up capital is INR 98,060.00 .
Irx Pharmaceuticals's operating revenue range is INR 1 cr - 100 cr for the financial year ending on 31 March, 2023. It's EBITDA has increased by 87.45% over the previous year. At the same time, it's book networth has increased by 195.24%.
Read more
Buy Dashboard using Credits
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
** All rupee values in INR lacs. Based on March 2023 numbers.
91.58%
87.45%
90.17%
195.24%
176.04%
2.18
-1.43
-0.82
-36.54
-49.94
Buy Report or Plans
Company dashboard
Five year financials and ratios
Risk analysis
Interactive charts
Latest financials
Latest annual return
MoA and AoA
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(2)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO |
| Networth | |||
| Borrowings | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO |
| Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO |
| Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO |
| Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|
| Solvency + | |||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO |
| Liquidity + | |||
| Current Ratio | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO |
| Performance | |||
| Gross Margin | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO |
| Return + | |||
| Return on Equity | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO |
| Efficiency + | |||
| Days Payable | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO |
| Working Capital | |||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO |
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Ritika Sachdev Gupta | 01054893 | 4 years |
| Director | Mahipal Singh Sachdev | 01062034 | 4 years |
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| NEW VISION LASER CENTERS (HYDERABAD) PRIVATE LIMITED |
Amalgamated
|
1.4 Cr | 2 | Maharashtra |
| DR. KHUNGER EYE CARE AND RESEARCH CENTRE PRIVATE LIMITED |
Active
|
1.0 L | 2 | Delhi |
| CFS NETRALAYA PRIVATE LIMITED |
Active
|
1.9 Cr | 2 | Maharashtra |
| NDCFS FOUNDATION |
Active
|
1.0 L | 2 | Delhi |
| CHALLA EYE CARE PRIVATE LIMITED |
Active
|
31.5 L | 2 | Telangana |
| M M EYETECH PRIVATE LIMITED |
Active
|
2.0 Cr | 1 | Delhi |
| RIMS DESIGNER OPTICS PRIVATE LIMITED |
Active
|
20.0 L | 1 | Delhi |
| VISHWANETHRA HEALTH SERVICES PRIVATE LIMITED |
Active
|
50.0 L | 2 | Andhra Pradesh |
| SHRI DIVYADRASHTI LASER CLINIC PRIVATE LIMITED |
Active
|
69.0 L | 2 | Delhi |
| NEW DELHI CENTRE FOR SIGHT LIMITED |
Active
|
12.2 Cr | 2 | Maharashtra |
| NEW VISION LASER CENTERS (RAJKOT) PRIVATE LIMITED |
Amalgamated
|
1.0 Cr | 1 | Maharashtra |
| CFS PHARMA AND OPTICALS PRIVATE LIMITED |
Active
|
1.0 L | 1 | Delhi |
| SHREE HI-TECH CLINICS PRIVATE LIMITED |
Active
|
54.1 L | 1 | Delhi |
The incorporation date of IRX PHARMACEUTICALS PRIVATE LIMITED is 14 October, 2020
The authorized share capital of IRX PHARMACEUTICALS PRIVATE LIMITED is INR ₹ 1.0 L.
The paid-up capital of IRX PHARMACEUTICALS PRIVATE LIMITED is INR ₹ 98,060.0 .
The registered address of IRX PHARMACEUTICALS PRIVATE LIMITED is B-5/24 Safdarjung Enclave NA New Delhi South Delhi Delhi - 110029
The CIN number of IRX PHARMACEUTICALS PRIVATE LIMITED is U24110DL2020PTC371543.
Expand
Delete
Collapse
See
details
